Multimodality treatment in unresectable cholangiocarcinoma

PURPOSE: Cholangiocarcinomas (CCs) are rare and highly malignant cancers. Although there are different treatment protocols for treatment of cholangiocarcinoma, we aimed to investigate a survival rate of patients with unresectable extrahepatic CCs (ECCs) receiving multimodality therapeutic protocol (...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghili, Mahdi, Saberi, Hazhir, zadeh, Mahtab Mojtahed, Jafari, Fatemeh, Mehrabinejad, Mohammad-Mehdi, Dashti, Habibollah, Saberi, Pejman, Yazdi, Niloofar Ayoobi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207240/
https://www.ncbi.nlm.nih.gov/pubmed/32395137
http://dx.doi.org/10.5114/jcb.2020.94582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207240/
https://www.ncbi.nlm.nih.gov/pubmed/32395137
http://dx.doi.org/10.5114/jcb.2020.94582

Ejemplares similares